<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2983306R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3565</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsia</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia</journal-id>
<journal-title-group>
<journal-title>Epilepsia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9580</issn>
<issn pub-type="epub">1528-1167</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31313283</article-id>
<article-id pub-id-type="pmc">7098045</article-id>
<article-id pub-id-type="doi">10.1111/epi.16285</article-id>
<article-id pub-id-type="manuscript">NIHMS1037781</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>CDKL5 Deficiency Disorder: Relationship between genotype, epilepsy, cortical visual impairment and development.</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Demarest</surname>
<given-names>Scott T.</given-names>
</name>
<degrees>MD</degrees>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4544-3724</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olson</surname>
<given-names>Heather E.</given-names>
</name>
<degrees>MD, MS</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moss</surname>
<given-names>Angela</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pestana-Knight</surname>
<given-names>Elia</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A11">11</xref>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiaoming</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A11">11</xref>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parikh</surname>
<given-names>Sumit</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A12">12</xref>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Swanson</surname>
<given-names>Lindsay C.</given-names>
</name>
<degrees>MS, CGC</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riley</surname>
<given-names>Katherine D.</given-names>
</name>
<degrees>BA</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bazin</surname>
<given-names>Grace A.</given-names>
</name>
<degrees>BSN, RN</degrees>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Angione</surname>
<given-names>Katie</given-names>
</name>
<degrees>MS, CGC</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niestroj</surname>
<given-names>Lisa-Marie</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6986-0549</contrib-id>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lal</surname>
<given-names>Dennis</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A10">10</xref>
<xref ref-type="aff" rid="A13">13</xref>
<xref ref-type="aff" rid="A14">14</xref>
<xref ref-type="aff" rid="A15">15</xref>
<xref ref-type="aff" rid="A16">16</xref>
<xref ref-type="aff" rid="A17">17</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Juarez-Colunga</surname>
<given-names>Elizabeth</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Benke</surname>
<given-names>Tim A.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Children’s Hospital Colorado, Aurora, CO, 80045, USA.</aff>
<aff id="A2"><label>2</label>Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), Aurora, CO, 80045, USA.</aff>
<aff id="A3"><label>3</label>University of Colorado School of Medicine, Aurora, CO, 80045, USA.</aff>
<aff id="A4"><label>4</label>Department of Pediatrics, Aurora, CO, 80045, USA.</aff>
<aff id="A5"><label>5</label>Department of Pharmacology, Aurora, CO, 80045, USA.</aff>
<aff id="A6"><label>6</label>Department of Neurology, Aurora, CO, 80045, USA.</aff>
<aff id="A7"><label>7</label>Department of Otolaryngology, Aurora, CO, 80045, USA.</aff>
<aff id="A8"><label>8</label>Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, 80045, USA.</aff>
<aff id="A9"><label>9</label>Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Boston Children’s Hospital, Boston, MA, 02115 USA.</aff>
<aff id="A10"><label>10</label>Cleveland Clinic Neurological Institute Epilepsy Center, Cleveland Clinic Neurological Institute Pediatric</aff>
<aff id="A11"><label>11</label>Neurology Department, Cleveland, OH.</aff>
<aff id="A12"><label>12</label>Neurogenetics, Cleveland, OH.</aff>
<aff id="A13"><label>13</label>Genomic Medicine Institute, Lerner Research Institute, Cleveland, OH.</aff>
<aff id="A14"><label>14</label>Cleveland Clinic Children’s, Cleveland, OH.</aff>
<aff id="A15"><label>15</label>Cologne Center for Genomics, University of Cologne, Cologne, Germany</aff>
<aff id="A16"><label>16</label>Stanley Center for Psychiatric Research, Cambridge, MA 02142, USA</aff>
<aff id="A17"><label>17</label>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</aff>
<author-notes>
<corresp id="CR1">Corresponding Author: Scott Demarest, 13123 E 16<sup>th</sup> St B155, Aurora, CO 80045, 720-777-1003, Fax: 720-777-7285, <email>Scott.demarest@childrenscolorado.org</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P27">Disclosures of Conflicts of Interest</p>
</fn>
<fn fn-type="COI-statement" id="FN2">
<p id="P28">Dr. Demarest has consulted for Upsher Smith and BioMarin on subject matter unrelated to this project and sits on the advisory board for the SLC6A1 Connect family foundation. Dr. Benke has consulted for IFCR, LouLou foundation, Marinus, Avexis, Takeda, Ovid, Adadia and Neuren. Dr. Olson has consulted for Takeda. All other authors have no conflicts of interests or disclosures.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>60</volume>
<issue>8</issue>
<fpage>1733</fpage>
<lpage>1742</lpage>
<!--elocation-id from pubmed: 10.1111/epi.16285-->
<abstract id="ABS1">
<sec id="S1">
<title>Objective:</title>
<p id="P1">The cyclin-dependent kinase-like 5 (<italic>CDKL5</italic>) gene is a known cause of early onset developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder (CDD). We sought to provide 1) a description of seizure types in patients with CDD; 2) an assessment of the frequency of seizure free periods and cortical visual impairment (CVI); 3) correlate these features with genotype and gender; and 4) correlate these features with developmental milestones.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P2">This is a cohort study of patients with CDD. Phenotypic features were explored and correlated with gene variant grouping<sup><xref ref-type="bibr" rid="R1">1</xref></sup> and gender. A developmental score was created based on achieving seven primary milestones. Phenotypic variables were correlated with the developmental score to explore markers of better developmental outcomes. Multivariable linear regression was used to account for age at last visit.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P3">Ninety-two patients with CDD were seen during the enrollment period. Eighteen were male (19%) and with a median age at last visit of 5 years (IQR 2.0, 11.0). Eighty-one percent of patients developed epileptic spasms but only 47% of those also had hypsarrhythmia. Previously described hypertonic-spasm-sequence (HTSS) was seen in only 24% of patients but 56% of patients had seizures with multiple phases (often tonic and spasms). Forty-three percent of patients experienced a seizure free period ranging from 1 to more than 12 months, but only 6% were still seizure free at the last visit. CVI was present in 75% of all CDD patients. None of these features were associated with genotype group or gender. Cortical visual impairment was correlated with reduced milestone achievement after adjusting for age at last visit and a history of hypsarrhythmia.</p>
</sec>
<sec id="S4">
<title>Significance:</title>
<p id="P4">The most common seizure types in CDD are epileptic spasms (often without hypsarrhythmia) and tonic seizures that may cluster together. CVI is a common feature in CDD and is correlated with achieving fewer milestones.</p>
</sec>
</abstract>
<kwd-group>
<kwd>CDD</kwd>
<kwd>CVI</kwd>
<kwd>spasms</kwd>
<kwd>hypsarrhythmia</kwd>
<kwd>Hypermotor Tonic-spasms sequence</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>